Index by author

March 1, 2025; Volume 66,Issue 3

  1. Macfarlane, James

    1. A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[<sup>18</sup>F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
      A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
      Daniel Gillett, Russell Senanayake, James MacFarlane, Waiel Bashari, August Palma, Lihua Hu, Ines Harper, Iosif A. Mendichovszky, Gunnar Antoni, Per Hellman, Anders Sundin, Matthew Hird, István Boros, Morris J. Brown, Heok Cheow, Luigi Aloj, Franklin Aigbirhio and Mark Gurnell
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 434-440; DOI: https://doi.org/10.2967/jnumed.124.268425

  2. Mankoff, David

    1. Kenneth A. Krohn, PhD, 1945–2024
      Janet Eary, Jeanne Link, David Mankoff, David Vera and Tom Ruth
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 486; DOI: https://doi.org/10.2967/jnumed.124.269449

  3. Manly, Lester S.

    1. PET Quantification in Healthy Humans of Cyclooxygenase-2, a Potential Biomarker of Neuroinflammation
      PET Quantification in Healthy Humans of Cyclooxygenase-2, a Potential Biomarker of Neuroinflammation
      Xuefeng Yan, Martin Noergaard, Cheryl L. Morse, Jeih-San Liow, Jinsoo Hong, Douglas Greve, Sanjay Telu, Min-Jeong Kim, Jose A. Montero Santamaria, Anthony Galassi, Ningping Feng, Sarah K. Williams Avram, Ted B. Usdin, Shawn Wu, Andrea Zhang, Lester S. Manly, Madeline Jenkins, Maia Van Buskirk, Adrian Lee, Sami S. Zoghbi, Victor W. Pike, Paolo Zanotti-Fregonara and Robert B. Innis
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 398-404; DOI: https://doi.org/10.2967/jnumed.124.268525

  4. Mariani, Maurizio F.

    1. Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
      Open Access
      Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
      Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Erik S. Mittra, Harshad R. Kulkarni, Christophe M. Deroose, Rajaventhan Srirajaskanthan, John Ramage, Chiara Maria Grana, Francesca Botta, Matthias M. Weber, Matthias Miederer, Ryan Reddy, Daniela Chicco, Maurizio F. Mariani, Arnaud Demange, Jack L. Erion, Germo Gericke and Eric Krenning
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 449-456; DOI: https://doi.org/10.2967/jnumed.124.268903

  5. Marquis, Harry

    1. MIRD Pamphlet No. 32: A MIRD Recovery Coefficient Model for Resolution Characterization and Shape-Specific Partial-Volume Correction
      Harry Marquis, C. Ross Schmidtlein, Robin de Nijs, Pablo Mínguez Gabiña, Johan Gustafsson, Gunjan Kayal, Juan C. Ocampo Ramos, Lukas M. Carter, Dale L. Bailey and Adam L. Kesner
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 457-465; DOI: https://doi.org/10.2967/jnumed.124.268520

  6. Mcdonald, Alexander F.

    1. DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of <sup>177</sup>Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma
      DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of 177Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma
      Cameron N. Johnstone, Laura D. Osellame, Zhipeng Cao, Alexander F. McDonald, Angela Rigopoulos, Ingrid J.G. Burvenich, Christian W. Wichmann, Nancy Guo, Alesia N. Ivashkevich, Michael P. Wheatcroft, Edwin B. Yan, Astrid Zimmermann, Frank T. Zenke, Christian Sirrenberg, Fiona E. Scott and Andrew M. Scott
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 385-390; DOI: https://doi.org/10.2967/jnumed.124.268695

  7. Mendichovszky, Iosif A.

    1. A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[<sup>18</sup>F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
      A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
      Daniel Gillett, Russell Senanayake, James MacFarlane, Waiel Bashari, August Palma, Lihua Hu, Ines Harper, Iosif A. Mendichovszky, Gunnar Antoni, Per Hellman, Anders Sundin, Matthew Hird, István Boros, Morris J. Brown, Heok Cheow, Luigi Aloj, Franklin Aigbirhio and Mark Gurnell
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 434-440; DOI: https://doi.org/10.2967/jnumed.124.268425

  8. Miederer, Isabelle

    1. Dopaminergic Mechanisms of Cognitive Flexibility: An [<sup>18</sup>F]Fallypride PET Study
      Dopaminergic Mechanisms of Cognitive Flexibility: An [18F]Fallypride PET Study
      Isabelle Miederer, Hans-Georg Buchholz, Lena Rademacher, Cindy Eckart, Dominik Kraft, Markus Piel, Christian J. Fiebach and Mathias Schreckenberger
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 405-409; DOI: https://doi.org/10.2967/jnumed.124.268317

  9. Miederer, Matthias

    1. Dosimetry of [<sup>177</sup>Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
      Open Access
      Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial
      Lisa Bodei, Marta Cremonesi, Mahila Ferrari, Erik S. Mittra, Harshad R. Kulkarni, Christophe M. Deroose, Rajaventhan Srirajaskanthan, John Ramage, Chiara Maria Grana, Francesca Botta, Matthias M. Weber, Matthias Miederer, Ryan Reddy, Daniela Chicco, Maurizio F. Mariani, Arnaud Demange, Jack L. Erion, Germo Gericke and Eric Krenning
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 449-456; DOI: https://doi.org/10.2967/jnumed.124.268903

  10. Minguez Gabina, Pablo

    1. MIRD Pamphlet No. 32: A MIRD Recovery Coefficient Model for Resolution Characterization and Shape-Specific Partial-Volume Correction
      Harry Marquis, C. Ross Schmidtlein, Robin de Nijs, Pablo Mínguez Gabiña, Johan Gustafsson, Gunjan Kayal, Juan C. Ocampo Ramos, Lukas M. Carter, Dale L. Bailey and Adam L. Kesner
      Journal of Nuclear Medicine March 1, 2025, 66 (3) 457-465; DOI: https://doi.org/10.2967/jnumed.124.268520
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue